IL82459A - Stabilized pharmaceutical preparations containing polyunsaturated fatty acids and stimulating the synthesis of prostaglandins and hydroxy- and fatty acids in B systems - Google Patents

Stabilized pharmaceutical preparations containing polyunsaturated fatty acids and stimulating the synthesis of prostaglandins and hydroxy- and fatty acids in B systems

Info

Publication number
IL82459A
IL82459A IL8245987A IL8245987A IL82459A IL 82459 A IL82459 A IL 82459A IL 8245987 A IL8245987 A IL 8245987A IL 8245987 A IL8245987 A IL 8245987A IL 82459 A IL82459 A IL 82459A
Authority
IL
Israel
Prior art keywords
fatty acids
acid
prostaglandins
unsaturated fatty
stimulators
Prior art date
Application number
IL8245987A
Other languages
English (en)
Hebrew (he)
Other versions
IL82459A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL82459A0 publication Critical patent/IL82459A0/xx
Publication of IL82459A publication Critical patent/IL82459A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL8245987A 1986-05-09 1987-05-08 Stabilized pharmaceutical preparations containing polyunsaturated fatty acids and stimulating the synthesis of prostaglandins and hydroxy- and fatty acids in B systems IL82459A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863615710 DE3615710A1 (de) 1986-05-09 1986-05-09 Zubereitungen fuer die synthese von prostaglandinen und hydroxyfettsaeuren in biologischen systemen

Publications (2)

Publication Number Publication Date
IL82459A0 IL82459A0 (en) 1987-11-30
IL82459A true IL82459A (en) 1994-07-31

Family

ID=6300504

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8245987A IL82459A (en) 1986-05-09 1987-05-08 Stabilized pharmaceutical preparations containing polyunsaturated fatty acids and stimulating the synthesis of prostaglandins and hydroxy- and fatty acids in B systems

Country Status (16)

Country Link
US (1) US5043328A (ko)
EP (1) EP0244832B1 (ko)
JP (1) JPS62267222A (ko)
KR (1) KR950008306B1 (ko)
AT (1) ATE77549T1 (ko)
AU (1) AU603574B2 (ko)
CA (1) CA1302266C (ko)
DE (2) DE3615710A1 (ko)
DK (1) DK167518B1 (ko)
ES (1) ES2051705T3 (ko)
GR (1) GR3005768T3 (ko)
HU (1) HU201671B (ko)
IE (1) IE60273B1 (ko)
IL (1) IL82459A (ko)
PT (1) PT84841B (ko)
ZA (1) ZA873299B (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8383678B2 (en) 2004-02-13 2013-02-26 Chrysalis Pharma Ag Type a gelatin capsule containing PUFA in free acid form

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334612A (en) * 1988-11-09 1994-08-02 Asta Pharma Aktiengesellschaft Pharmaceutical compositions containing as active substance sulphur-containing carboxylic acids and their use in combating retroviruses
FR2639828B1 (fr) * 1988-12-01 1993-11-05 Lvmh Recherche Utilisation du kaempferol et de certains de ses derives pour la preparation d'une composition cosmetique ou pharmaceutique
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
US5399584A (en) * 1992-05-05 1995-03-21 The Procter & Gamble Company Use of flavone derivatives for gastroprotection
US5569670A (en) * 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related
CA2151820C (en) * 1993-01-15 2000-11-28 Stephen Joseph Demichele Structured lipids
GB9715444D0 (en) 1997-07-22 1997-09-24 Scotia Holdings Plc Therapeutic and dietary compositions
CA2704975A1 (en) * 1999-10-13 2001-05-31 Marco A. Chacon Therapeutic intervention to mimic the effect of caloric restriction
IL149421A0 (en) * 1999-11-02 2002-11-10 Depomed Inc Pharmaceutical compositions containing fed mode inducing agents
US6228367B1 (en) * 1999-12-22 2001-05-08 Renew Life, Inc. Food supplement formulation
CA2304906A1 (en) * 2000-04-07 2001-10-07 1411198 Ontario Limited 13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
US7098352B2 (en) * 2001-11-16 2006-08-29 Virtus Nutrition Llc Calcium salt saponification of polyunsaturated oils
US20040048919A1 (en) * 2002-07-02 2004-03-11 Dreon Darlene M. Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
US20050164908A1 (en) * 2004-01-23 2005-07-28 Ginsberg Myron D. Neuroprotective complex for treatment of cerebral ischemia and injury
EP1765964A4 (en) * 2004-04-30 2007-11-07 SYNTHESIS OF METALLIC SALTS OF MONOVALENT AND DIVALENT POLYUNSATURATED FATTY ACIDS
WO2006054316A1 (en) * 2004-11-16 2006-05-26 Magene Life Sciences Private Limited Method(s) of preparation, stabilization, composition, and administration of gamma-linolenic acid for brain tumors
US20070082063A1 (en) * 2005-10-11 2007-04-12 Douglas Bibus Risk assessment and correction of membrane damage of the upper GI tract
AU2009309237B2 (en) * 2008-10-31 2016-02-25 Lipid Pharmaceuticals Ehf. Fatty acids for use as a medicament
KR20130102037A (ko) * 2010-07-22 2013-09-16 메르츠 파마 게엠베하 운트 코. 카가아 트립토판 유도체를 함유하는 약학 조성물
WO2013087808A1 (en) 2011-12-15 2013-06-20 Merz Pharma Gmbh & Co. Kgaa Pharmaceutical composition comprising a pyrazolopyrimidme and cyclodextrin
CN104583305B (zh) 2012-04-16 2017-09-26 罗地亚经营管理公司 含氟聚合物组合物
GB201216385D0 (en) 2012-09-13 2012-10-31 Chrysalis Pharma Ag A pharmaceutical composition
AU2014225619A1 (en) * 2013-03-06 2015-10-15 Rutgers, The State University Of New Jersey Nutritional supplement/feed formula and methods of use thereof to reduce development of Osteochondrosis Dissecans (OCD) lesions

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE237029C (ko) *
FR2197605A1 (en) * 1972-09-06 1974-03-29 Williams John Foodstuff or skin nutrient to combat cholesterolaemia - contains arachidonic acid or gamma linolenic acid or esters and salts thereof
JPS537492B2 (ko) * 1973-02-12 1978-03-18
GB1476624A (en) * 1973-05-30 1977-06-16 Cepbepe Tranquiliser medicaments
DE2813814A1 (de) * 1978-03-31 1979-10-18 Boehringer Mannheim Gmbh Hochwirksame, enteral resorbierbare pharmazeutische praeparate
IE53332B1 (en) * 1980-03-14 1988-10-26 Efamol Ltd Pharmaceutical compositions
JPS5735512A (en) * 1980-06-27 1982-02-26 Nippon Oil & Fats Co Ltd Preventive and remedy for thrombosis
JPS5813541A (ja) * 1981-07-16 1983-01-26 Kureha Chem Ind Co Ltd エイコサペンタエン酸又はドコサヘキサエン酸のシクロデキストリン包接化合物
EP0087865B1 (en) * 1982-03-01 1986-10-01 Efamol Limited Pharmaceutical composition
FR2522935A1 (fr) * 1982-03-10 1983-09-16 Chevalier Jacques Nouveaux produits a base de lait et de ses derives riches en acides gras polyinsatures et leur procede de preparation
JPS58164508A (ja) * 1982-03-26 1983-09-29 Eisai Co Ltd イソプレニルカルボン酸含有外用組成物
ATE22533T1 (de) * 1982-04-29 1986-10-15 Efamol Ltd Pharmazeutische zusammensetzung.
US4668704A (en) * 1982-08-09 1987-05-26 Regents Of The University Of California Method for protecting and healing gastro-duodenal mucosa and the liver of mammals
ATE55056T1 (de) * 1982-12-09 1990-08-15 Advanced Drug Tech Einfach absorbierbare fettsaeureemulsionen.
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
CA1218376A (en) * 1983-05-28 1987-02-24 Sekimoto, Hiroshi Compositions containing unsaturated fatty acid compounds and method of stabilizing unsaturated fatty acid compounds
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
DE3470277D1 (en) * 1984-01-11 1988-05-11 Von Mletzko Armin Dietetic composition
JPS60184011A (ja) * 1984-03-02 1985-09-19 Itaru Yamamoto 免疫調節剤
IT1176916B (it) * 1984-10-10 1987-08-18 Elvira Pistolesi Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
JPS62187425A (ja) * 1985-10-14 1987-08-15 Michio Nakanishi リノレン酸系化合物含有組成物
DE3719097C1 (de) * 1987-06-06 1988-06-09 Fratzer Uwe Arzneimittel,enthaltend Eicosapentaensaeure und Docosahexaensaeure als ungesaettigte Fettsaeuren sowie Vitamin E

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8383678B2 (en) 2004-02-13 2013-02-26 Chrysalis Pharma Ag Type a gelatin capsule containing PUFA in free acid form
US9012501B2 (en) 2004-02-13 2015-04-21 Chrysalis Pharma Ag Type A gelatin capsule containing PUFA in free acid form
US9132112B2 (en) 2004-02-13 2015-09-15 Chysalis Pharma Ag Type A gelatin capsule containing PUFA in free acid form

Also Published As

Publication number Publication date
DK235687D0 (da) 1987-05-08
DK167518B1 (da) 1993-11-15
EP0244832A3 (en) 1989-11-29
EP0244832A2 (de) 1987-11-11
EP0244832B1 (de) 1992-06-24
KR950008306B1 (ko) 1995-07-27
JPS62267222A (ja) 1987-11-19
DK235687A (da) 1987-11-10
GR3005768T3 (ko) 1993-06-07
HU201671B (en) 1990-12-28
US5043328A (en) 1991-08-27
HUT44433A (en) 1988-03-28
IL82459A0 (en) 1987-11-30
DE3615710A1 (de) 1987-11-26
CA1302266C (en) 1992-06-02
DE3779958D1 (de) 1992-07-30
ATE77549T1 (de) 1992-07-15
IE871203L (en) 1987-11-09
ZA873299B (en) 1987-11-02
PT84841B (pt) 1990-02-08
AU7264187A (en) 1987-11-12
AU603574B2 (en) 1990-11-22
ES2051705T3 (es) 1994-07-01
PT84841A (de) 1987-06-01
KR870010867A (ko) 1987-12-18
IE60273B1 (en) 1994-06-29

Similar Documents

Publication Publication Date Title
US5043328A (en) Formulations containing unsaturated fatty acids for the synthesis of prostaglandins and hydroxy-fatty acids in biological systems
RU2080116C1 (ru) Средство для лечения болей или воспалений
JPH01121300A (ja) 乳汁に由来するポリペプチド成長因子
JP3285410B2 (ja) アントシアノシド類を含有する経口医薬組成物
JP3801225B2 (ja) アミノアルコール類の塩およびこれを含有する医薬処方物
US4910224A (en) Method of modifying the lipid structure and function of cell membranes and pharmaceutical compositions for use therein
IE72479B1 (en) Codeine salt of a substituted carbonacid process of its preparation its use and pharmaceutical preparations
WO1992002231A1 (fr) Agent anti-vih
AU609428B2 (en) Use of carboxylic acid amides
JPS60120995A (ja) 新規アミノ酸誘導体の製法
JPS58206524A (ja) 抗腫瘍剤
JP2642198B2 (ja) 胃粘膜障害治療剤
EP1153010A1 (en) $i(N)-SUBSTITUTED AMINO ACIDS, ANTIOXIDANT PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND METHODS USING SAME
FR2649322A1 (fr) Complexes biodisponibles d'acide (alpha)-linolenique, extraits de plantes en contenant et compositions pharmaceutiques les incorporant
AU701287B2 (en) The pharmacological use of certain cystine derivatives
JPS6248622A (ja) 癌転移抑制剤
KR960014874B1 (ko) 요산 배출용 조성물
JPH0466538A (ja) 抗潰瘍剤
JPS61204122A (ja) 肝臓疾患治療剤
US5028439A (en) Inhibition of parathyroid hormone secretion
JPH0665084A (ja) 抗ウイルス剤
JPH0144196B2 (ko)
JPS58208224A (ja) 抗腫瘍剤
JPH0158162B2 (ko)
JPS63264409A (ja) 制癌剤

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees